Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Blood|May 23, 1998
BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phaseP de Fabritiis, M C Petti, E Montefusco, et al.
Annals of Hematology|July 2, 2003
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemiasM C Petti, A Tafuri, R Latagliata, et al.
Oncogene|September 12, 2012
miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemiaA Pelosi, S Careccia, V Lulli, et al.
Blood|September 25, 1999
Therapy of molecular relapse in acute promyelocytic leukemiaF Lo Coco, D Diverio, G Avvisati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2005
Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moonR Latagliata, V Bongarzoni, I Carmosino, et al.
Blood|June 20, 1998
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid MetaplasiaG Barosi, A Ambrosetti, A Centra, et al.
Leukemia|June 1, 2002
Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'?M Breccia, M C Petti, A M Testi, et al.
Experimental Hematology|July 31, 1999
Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cellsA Tafuri, R M Lemoli, M T Petrucci, et al.
Blood|July 29, 1998
Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" TrialD Diverio, V Rossi, G Avvisati, et al.
British Journal of Haematology|September 30, 1998
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoS Keating, T de Witte, S Suciu, et al.
Pageof 11